LimbuStem is a research and development (R&D), producing and delivering company in the field of advanced therapy medicinal products (ATMPs). LimbuStem is a techno-entrepreneurship (start-up) company supported by The Scientific and Technological Research Council of Turkey (TÜBİTAK). Headquartered in Izmir, Turkey. Today, LimbuStem focuses on developing, producing and marketing in vitro expanded corneal epithelial stem cells for patient-specific treatment of damaged cornea. Besides, LimbuStem's bioengineers focus on processing/preparing of human amniotic membrane for directly clinical use. LimbuStem produces/processes all advanced therapy products at full licensed/certified GMP laboratories in accordance with legal regulations.